Cargando…

Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling

Notch signaling regulates normal stem cells and is also thought to regulate cancer stem cells (CSCs). Recent data indicate that Notch signaling plays a role in the development and progression of osteosarcoma, however the regulation of Notch in chemo-resistant stem-like cells has not yet been fully e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Ling, Fan, Zhengfu, Fang, Shuo, Yang, Jian, Gao, Tian, Simões, Bruno M., Eyre, Rachel, Guo, Weichun, Clarke, Robert B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078075/ https://www.ncbi.nlm.nih.gov/pubmed/27102300 http://dx.doi.org/10.18632/oncotarget.8849

Ejemplares similares

Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail
por: Fang, Shuo, et al.
Publicado: (2016)

Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity
por: Yu, Ling, et al.
Publicado: (2013)

Cisplatin-resistant osteosarcoma cells possess cancer stem cell properties in a mouse model
por: Yang, Jian, et al.
Publicado: (2016)

Human umbilical vein endothelial cells derived-exosomes promote osteosarcoma cell stemness by activating Notch signaling pathway
por: Yang, Jian, et al.
Publicado: (2021)

Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines
por: Yang, Jian, et al.
Publicado: (2017)

The synergistic antitumor effect of cinobufagin and cisplatin in human osteosarcoma cell line in vitro and in vivo
por: Dai, Guo, et al.
Publicado: (2017)

Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells
por: Zhang, Zhengpei, et al.
Publicado: (2017)

miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1
por: Guo, Xiaodong, et al.
Publicado: (2017)

Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway
por: Ji, Peng, et al.
Publicado: (2015)

NOTCH Signaling in Osteosarcoma
por: Zhang, Zhenhao, et al.
Publicado: (2023)

miR-1270 enhances the proliferation, migration, and invasion of osteosarcoma via targeting cingulin
por: Liu, Yang, et al.
Publicado: (2021)

Construction of recombinant pEGFP-N1-hPer2 plasmid and its expression in osteosarcoma cells
por: CHENG, ANYUAN, et al.
Publicado: (2016)

MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1
por: Liu, Quanxiang, et al.
Publicado: (2018)

KIF18B promotes tumor progression in osteosarcoma by activating β-catenin
por: Gao, Tian, et al.
Publicado: (2020)

Targeting Notch1 signaling pathway positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase family
por: Wang, Lei, et al.
Publicado: (2014)

MicroRNA‑224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
por: Geng, Shuo, et al.
Publicado: (2016)

Relationship between red cell distribution width and prognosis of patients with osteosarcoma
por: Zheng, Jian, et al.
Publicado: (2019)

A Role for Notch Signalling in Breast Cancer and Endocrine Resistance
por: Acar, Ahmet, et al.
Publicado: (2016)

CD271(+) Osteosarcoma Cells Display Stem-Like Properties
por: Tian, Jiguang, et al.
Publicado: (2014)

Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling
por: Harrison, Hannah, et al.
Publicado: (2013)

Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity
por: Simões, Bruno M., et al.
Publicado: (2015)

Osteosarcoma contains a subpopulation of cancer stem-like cells that are highly resistant to radiotherapy
por: Neves, Sara RM, et al.
Publicado: (2010)

The role of Notch signaling in endometrial mesenchymal stromal/stem-like cells maintenance
por: Zhang, Sisi, et al.
Publicado: (2022)

Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients
por: Tang, Xue-Feng, et al.
Publicado: (2019)

Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages
por: Wang, Jincheng, et al.
Publicado: (2022)

β‐Elemene Selectively Inhibits the Proliferation of Glioma Stem‐Like Cells Through the Downregulation of Notch1
por: Feng, Hai‐bin, et al.
Publicado: (2016)

Carboxymethyl chitosan-alginate enhances bone repair effects of magnesium phosphate bone cement by activating the FAK-Wnt pathway
por: Yu, Ling, et al.
Publicado: (2022)

Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy
por: Gu, Jian-Wei, et al.
Publicado: (2012)

CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway
por: Cheng, Jun, et al.
Publicado: (2022)

Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line
por: Martins-Neves, Sara R, et al.
Publicado: (2012)

NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma
por: Huang, Jin-Cheng, et al.
Publicado: (2017)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin
por: Liu, Qing, et al.
Publicado: (2020)

Identification of genes contributing to cisplatin resistance in osteosarcoma cells
por: Xie, Mingzhong, et al.
Publicado: (2022)

ITGB3 promotes cisplatin resistance in osteosarcoma tumors
por: Li, Qian, et al.
Publicado: (2023)

A Novel Six Metastasis-Related Prognostic Gene Signature for Patients With Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2021)

LncRNA PLAC 2 Is Downregulated in Osteosarcoma and Regulates Cancer Cell Proliferation Through miR-93
por: Sun, Xiangran, et al.
Publicado: (2020)

Knockdown of the oncogene lncRNA NEAT1 restores the availability of miR-34c and improves the sensitivity to cisplatin in osteosarcoma
por: Hu, Yuliang, et al.
Publicado: (2018)

β-Elemene Enhances the Sensitivity of Osteosarcoma Cells to Doxorubicin via Downregulation of Peroxiredoxin-1
por: Zhang, Shaochun, et al.
Publicado: (2021)

The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair
por: Xu, Liang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sim5u96q2ruh45ldg272h7dvbq